Data Protection in China: 17 Years after China's WTO Accession

dc.contributor.authorCheng, Wenting
dc.date.accessioned2019-12-09T01:12:28Z
dc.date.issued2018
dc.date.updated2019-07-28T08:17:41Z
dc.description.abstractChina introduced dual data protection (both undisclosed information and six-year data exclusivity) for pharmaceutical products from its accession to the WTO. From 2017, a new series of policies proposed up to 12 years of data exclusivity for biologics. The drug negotiation mechanism in China should be considered in evaluating the impacts of these policies on enhanced data protectionen_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0142-0461en_AU
dc.identifier.urihttp://hdl.handle.net/1885/188490
dc.language.isoen_AUen_AU
dc.publisherSweet & Maxwell Ltden_AU
dc.rights© 2019 Thomson Reuters and Contributorsen_AU
dc.sourceEuropean Intellectual Property Review (E.I.P.R)en_AU
dc.titleData Protection in China: 17 Years after China's WTO Accessionen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue5en_AU
local.bibliographicCitation.lastpage297en_AU
local.bibliographicCitation.startpage292en_AU
local.contributor.affiliationCheng, Wenting, College of Asia and the Pacific, ANUen_AU
local.contributor.authoruidCheng, Wenting, u5467927en_AU
local.description.embargo2037-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor180199 - Law not elsewhere classifieden_AU
local.identifier.absseo949999 - Law, Politics and Community Services not elsewhere classifieden_AU
local.identifier.absseo920499 - Public Health (excl. Specific Population Health) not elsewhere classifieden_AU
local.identifier.ariespublicationu2546238xPUB12en_AU
local.identifier.citationvolume41en_AU
local.publisher.urlhttps://legal.thomsonreuters.com.au/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Cheng_Data_Protection_in_China%3A_17_2018.pdf
Size:
326.36 KB
Format:
Adobe Portable Document Format